Mr. Speaker, one of the things we need to remember is that Canada as a country does not have very many drug manufacturers. We are a very small producer of drugs. We are very dependent on the rest of the world, and because drug production is a private sector industry, there is very little that one can do to force companies to move their prices up or down, or to interfere in their business decisions.
However, what one can do is to look at ways in which we can assist with the buying of generic drugs, providing incentives to generic companies in Canada to help them to continue to produce drugs because we know that it is generic drugs that are actually in shorter supply.